Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis.

Leukocytes play a major role in the development and progression of autoimmune diseases. We measured gene expression differences in leukocytes from patients that were antineutrophil cytoplasmic autoantibody (ANCA) positive, patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA), and healthy donors to explore potential pathways for clinical intervention. Leukocyte gene expression profiles were determined on Affymetrix U133A/B chips in 88 autoimmune patients, 28 healthy donors, and healthy donor leukocyte cell subtypes that were activated in vitro. Comparison of gene expression in leukocytes identified differentially expressed signature genes that distinguish each donor source. The microarray expression levels for many signature genes correlated with the clinical activity of small vessel vasculitis in the ANCA patients; a result confirmed by quantitative real time-polymerase chain reaction for 16 relevant genes. Comparison with in vitro-activated leukocyte subtypes from healthy donors revealed that the ANCA signature genes were expressed by neutrophils while the SLE signature genes were expressed in activated monocytes and T cells. We have found that leukocyte gene expression data can differentiate patients with RA, SLE, and ANCA-related small vessel vasculitis. Monitoring changes in the expression of specific genes may be a tool to help quantify disease activity during treatment.

[1]  T. Hayakawa,et al.  Change in annexin A3 expression by regulatory factors of hepatocyte growth in primary cultured rat hepatocytes. , 2006, Biological & pharmaceutical bulletin.

[2]  Joseph F. Clark,et al.  Gene Expression in Blood Changes Rapidly in Neutrophils and Monocytes after Ischemic Stroke in Humans: A Microarray Study , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Ryan M. O’Connell,et al.  MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. , 2006, Immunity.

[4]  R. Kettritz,et al.  Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. , 1997, Journal of the American Society of Nephrology : JASN.

[5]  A. Sabirsh,et al.  Pro‐ and anti‐inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes , 2005, Journal of leukocyte biology.

[6]  Ec Beachler.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003 .

[7]  D. Alcorta,et al.  ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. , 2000, Kidney international.

[8]  J. Ernst,et al.  Purification and characterization of an abundant cytosolic protein from human neutrophils that promotes Ca2(+)-dependent aggregation of isolated specific granules. , 1990, The Journal of clinical investigation.

[9]  R. Moots,et al.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. , 1994, QJM : monthly journal of the Association of Physicians.

[10]  D. Alcorta,et al.  Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. , 2004, Journal of the American Society of Nephrology : JASN.

[11]  P. Heeringa,et al.  The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. , 2005, The American journal of pathology.

[12]  R J Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Cattell,et al.  L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. , 1996, Kidney international.

[14]  H. Ohno.  Pathogenetic and clinical implications of non-immunoglobulin ; BCL6 translocations in B-cell non-Hodgkin's lymphoma. , 2006, Journal of clinical and experimental hematopathology : JCEH.

[15]  A. Ho,et al.  Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. , 2005, Blood.

[16]  S. Moss,et al.  Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.

[17]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[18]  Ash A. Alizadeh,et al.  Cell-type specific gene expression profiles of leukocytes in human peripheral blood , 2006, BMC Genomics.

[19]  E. Pearce,et al.  Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of l-Arginine Metabolism1 , 2001, The Journal of Immunology.

[20]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Tager,et al.  A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis , 2006, The Journal of experimental medicine.

[22]  D A Isenberg,et al.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.

[23]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[24]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[25]  B. Medoff,et al.  Antibody-antigen interaction in the airway drives early granulocyte recruitment through BLT1. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[26]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Fujikawa,et al.  Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. , 1988, Biochemistry.

[28]  V. Cattell,et al.  Arginase in glomerulonephritis. , 2002, Experimental nephrology.

[29]  A. Kolb,et al.  Suppression of T-cell functions by human granulocyte arginase. , 2006, Blood.

[30]  P. Heeringa,et al.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.

[31]  Sung Goo Park,et al.  Annexin A3 is a potential angiogenic mediator. , 2005, Biochemical and biophysical research communications.

[32]  T. Hayakawa,et al.  Expression of annexin A3 in primary cultured parenchymal rat hepatocytes and inhibition of DNA synthesis by suppression of annexin A3 expression using RNA interference. , 2005, Biological & pharmaceutical bulletin.

[33]  M. Crow,et al.  Microarray Analysis of Interferon-regulated Genes in SLE , 2003, Autoimmunity.

[34]  C. Kallenberg,et al.  Neutrophil‐activating potential of antineutrophil cytoplasm autoantibodies , 2003, Journal of leukocyte biology.

[35]  E. Schned,et al.  Derivation of the SLEDAI. , 1993, Arthritis and rheumatism.

[36]  J. Satriano.  Arginine pathways and the inflammatory response: Interregulation of nitric oxide and polyamines: Review article , 2004, Amino Acids.

[37]  J. Warren,et al.  Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. , 1995, The Journal of laboratory and clinical medicine.

[38]  S. Jones,et al.  Bactericidal/permeability‐increasing protein (BPI) is an important antigen for anti‐neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis , 1995, Clinical and experimental immunology.